A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human alpha(?) integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer

Heidenreich, A.; Rawal, S. K.; Szkarlat, K.; Bogdanova, N.; Dirix, L.; Stenzl, A.; Welslau, M.; Wang, G.; Dawkins, F.; de Boer, C. J.; Schrijvers, D.

dc.contributor.author	Stenzl, Arnulf
dc.date.accessioned	2013-07-19T09:06:03Z
dc.date.available	2013-07-19T09:06:03Z
dc.date.issued	2013
dc.identifier.issn	0923-7534
dc.identifier.uri	http://hdl.handle.net/10900/36120
dc.language.iso	en	en
dc.publisher	Oxford Univ Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1093/annonc/mds505
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human alpha(?) integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20130315161744_00101	de_DE
utue.publikation.seiten	329-336	de_DE
utue.personen.roh	Heidenreich, A.
utue.personen.roh	Rawal, S. K.
utue.personen.roh	Szkarlat, K.
utue.personen.roh	Bogdanova, N.
utue.personen.roh	Dirix, L.
utue.personen.roh	Stenzl, A.
utue.personen.roh	Welslau, M.
utue.personen.roh	Wang, G.
utue.personen.roh	Dawkins, F.
utue.personen.roh	de Boer, C. J.
utue.personen.roh	Schrijvers, D.
dcterms.isPartOf.ZSTitelID	Annals of Oncology	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	24	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE